Article | December 20, 2024

Due Diligence Decoded: Insights from In-House Counsel at Boston Program

Read More

Article | December 19, 2024

Exploring the Loper Decision: Impacts on FDA-Regulated Transactions

Read More

Article | December 18, 2024

Revealing Risk: Cybersecurity Due Diligence

Read More

Article | December 17, 2024

Honesty is the Best Policy: Navigating the DOJ’s M&A Safe Harbor

Read More

Article | December 15, 2024

Navigating the Complex Regulatory Landscape for AI/ML-Enabled Medical Devices

Read More

Article | December 10, 2024

Breaking the Ice: FDA-focused firm leader sees benefits in AI

Read More

Article | December 05, 2024

FDA Tightens Food Chemical Safety Rules

Read More

Article | December 03, 2024

LDT Compliance: Countdown to May 2025

Read More

Article | November 21, 2024

Post-Election FDA Landscape: Will There Be Regulatory Shifts Ahead in 2025 and Beyond?

Read More

Article | November 20, 2024

FDA Launches New Human Foods Program

Read More

Article | November 19, 2024

Best Practices for Responding to an FDA Form 483

Read More

Article | November 14, 2024

Surviving FDA Inspections: Proactive Preparation is Key

Read More